RAC1 and neoplasm: VEGF binding to VEGFR2 leads to activating and translocating RAC1 into the plasma membrane, whereas ROS-dependent signaling events may trigger angiogenesis (i.e., cell migration and proliferation) and influence MMP2, which affect growth factor, tumor promoter stimulation, and prognostic survival as well.